12.30
-0.64
(-4.95%)
At close: January 10 at 4:00:02 PM EST
12.40
+0.10
+(0.81%)
After hours: January 10 at 7:50:19 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.13 | -0.09 | -0.37 | -0.21 |
| Low Estimate | -0.14 | -0.1 | -0.38 | -0.3 |
| High Estimate | -0.11 | -0.08 | -0.35 | -0.14 |
| Year Ago EPS | -0.16 | -0.06 | -0.38 | -0.37 |
Revenue Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 70.3M | 74.23M | 284.91M | 303.8M |
| Low Estimate | 69.6M | 73.5M | 283.5M | 300.5M |
| High Estimate | 71M | 75.2M | 285.9M | 308.9M |
| Year Ago Sales | 65.97M | 70.98M | 303.91M | 284.91M |
| Sales Growth (year/est) | 6.56% | 4.58% | -6.25% | 6.63% |
Earnings History
| Currency in USD | 2/29/2024 | 5/31/2024 | 8/31/2024 | 11/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.17 | -0.15 | -0.11 |
| EPS Actual | -0.16 | -0.06 | -0.11 | -0.04 |
| Difference | -0.01 | 0.11 | 0.04 | 0.07 |
| Surprise % | -3.23% | 64.00% | 25.00% | 63.64% |
EPS Trend
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.09 | -0.37 | -0.21 |
| 7 Days Ago | -0.11 | -0.07 | -0.4 | -0.22 |
| 30 Days Ago | -0.11 | -0.07 | -0.4 | -0.22 |
| 60 Days Ago | -0.11 | -0.07 | -0.4 | -0.24 |
| 90 Days Ago | -0.11 | -0.07 | -0.4 | -0.24 |
EPS Revisions
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | -- |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | 3 | 3 | -- | 1 |
| Down Last 30 Days | 3 | 3 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANGO | 18.75% | -50.00% | 2.63% | 42.34% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/4/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 7/17/2024 |
Related Tickers
ATRC AtriCure, Inc.
31.41
-6.68%
AKYA Akoya Biosciences, Inc.
3.0300
+13.91%
POAI Predictive Oncology Inc.
1.3600
+1.49%
MBOT Microbot Medical Inc.
1.9300
+3.21%
PDEX Pro-Dex, Inc.
46.97
-5.49%
EKSO Ekso Bionics Holdings, Inc.
0.7890
+12.70%
MLSS Milestone Scientific Inc.
1.1800
-6.35%
MMSI Merit Medical Systems, Inc.
96.16
-2.02%
GCTK GlucoTrack, Inc.
0.1170
-15.71%
HAE Haemonetics Corporation
76.67
-1.83%